Hyphens Pharma International Limited 1J5.SI Stock
Hyphens Pharma International Limited Price Chart
Hyphens Pharma International Limited 1J5.SI Financial and Trading Overview
Hyphens Pharma International Limited stock price | 0.27 SGD |
Previous Close | 0.29 SGD |
Open | 0.29 SGD |
Bid | 0.28 SGD x 0 |
Ask | 0.29 SGD x 0 |
Day's Range | 0.29 - 0.29 SGD |
52 Week Range | 0.27 - 0.38 SGD |
Volume | 15.5K SGD |
Avg. Volume | 60.2K SGD |
Market Cap | 88.12M SGD |
Beta (5Y Monthly) | 0.235249 |
PE Ratio (TTM) | 7.125 |
EPS (TTM) | 0.03 SGD |
Forward Dividend & Yield | 0.01 (3.96%) |
Ex-Dividend Date | May 10, 2023 |
1y Target Est | 0.39 SGD |
1J5.SI Valuation Measures
Enterprise Value | 58.44M SGD |
Trailing P/E | 7.125 |
Forward P/E | 7.125 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.5635011 |
Price/Book (mrq) | 1.2723213 |
Enterprise Value/Revenue | 0.374 |
Enterprise Value/EBITDA | 4.311 |
Trading Information
Hyphens Pharma International Limited Stock Price History
Beta (5Y Monthly) | 0.235249 |
52-Week Change | -8.064% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.38 SGD |
52 Week Low | 0.27 SGD |
50-Day Moving Average | 0.31 SGD |
200-Day Moving Average | 0.32 SGD |
1J5.SI Share Statistics
Avg. Volume (3 month) | 60.2K SGD |
Avg. Daily Volume (10-Days) | 26.13K SGD |
Shares Outstanding | 309.2M |
Float | 57.93M |
Short Ratio | N/A |
% Held by Insiders | 81.41% |
% Held by Institutions | 1.29% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.1831 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.09% |
Operating Margin (ttm) | 7.59% |
Gross Margin | 38.60% |
EBITDA Margin | 8.66% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 156.38M SGD |
Revenue Per Share (ttm) | 0.51 SGD |
Quarterly Revenue Growth (yoy) | -15.19% |
Gross Profit (ttm) | 62.28M SGD |
EBITDA | 13.56M SGD |
Net Income Avi to Common (ttm) | 9.53M SGD |
Diluted EPS (ttm) | 0.04 |
Quarterly Earnings Growth (yoy) | -56.89% |
Balance Sheet
Total Cash (mrq) | 36.48M SGD |
Total Cash Per Share (mrq) | 0.12 SGD |
Total Debt (mrq) | 5.67M SGD |
Total Debt/Equity (mrq) | 8.07 SGD |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 0.224 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Hyphens Pharma International Limited
Country | Singapore |
State | N/A |
City | Singapore |
Address | 16 Tai Seng Street |
ZIP | 534138 |
Phone | 65 6338 8551 |
Website | https://www.hyphensgroup.com |
Industry | Pharmaceutical Retailers |
Sector(s) | Healthcare |
Full Time Employees | 350 |
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. The company operates through three segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital. The Specialty Pharma Principals segment markets and sells specialty pharmaceutical products, including Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine through distributorship or licensing, and supply agreements for the therapeutic areas, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedic and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, child psychiatry, and family medicine. The Proprietary Brands segment develops, markets, and sells dermatological products and health supplement products. This segment offers dermocosmetic products under the Ceradan and TDF brands through medical professionals; health supplement products under the Ocean Health brand directly to consumers via retail channels; and scalp care products under the CG 210 brand through medical professionals. The Medical Hypermart and Digital segment wholesales pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele-sales and sales representatives. The segment also operates an online B2B platform; and WellAway, an e-pharmacy. It also develops, markets, and sells proprietary generics, vaccines, and medical devices. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
Q&A For Hyphens Pharma International Limited Stock
What is a current 1J5.SI stock price?
Hyphens Pharma International Limited 1J5.SI stock price today per share is 0.27 SGD.
How to purchase Hyphens Pharma International Limited stock?
You can buy 1J5.SI shares on the SES exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hyphens Pharma International Limited?
The stock symbol or ticker of Hyphens Pharma International Limited is 1J5.SI.
Which industry does the Hyphens Pharma International Limited company belong to?
The Hyphens Pharma International Limited industry is Pharmaceutical Retailers.
How many shares does Hyphens Pharma International Limited have in circulation?
The max supply of Hyphens Pharma International Limited shares is 309.2M.
What is Hyphens Pharma International Limited Price to Earnings Ratio (PE Ratio)?
Hyphens Pharma International Limited PE Ratio is 9.00000100 now.
What was Hyphens Pharma International Limited earnings per share over the trailing 12 months (TTM)?
Hyphens Pharma International Limited EPS is 0.03 SGD over the trailing 12 months.
Which sector does the Hyphens Pharma International Limited company belong to?
The Hyphens Pharma International Limited sector is Healthcare.